Table 4.
A: sample containing rifampicin-resistant, mcr-1-positive E. coli of the expected phylogenetic group, obtained directly.
B: sample containing rifampicin-resistant, mcr-1-positive E. coli of the expected phylogenetic group, obtained after enrichment.
C: sample containing rifampicin-resistant, mcr-1-positive E. coli of an unexpected phylogenetic group and PFGE profile, obtained directly.
D: sample containing rifampicin-resistant, mcr-1-positive E. coli of an unexpected phylogenetic group and PFGE profile, obtained after enrichment (possibly transconjugant).
E: sample containing rifampicin-resistant, mcr-1-negative E. coli of the expected phylogenetic group and PFGE profile, obtained directly (possibly inoculated strain having lost the mcr-1 gene).
F: sample containing rifampicin-resistant, mcr-1-positive E. coli detected on CAO-CV medium.
NS: no sample.
Grey cells: clinical signs (diarrhea or temperature >40.0 °C).
*: pig resistant to E. coli F4.